It’s been a busy week for Influenza researchers. A multitude of reports have been released documenting new findings.
– A group of NIH scientists have developed a vaccine that protects mice from the 1918 flu strain. This was accomplished by identifying antibodies (Ab) which neutralize the virus.
– A H5N1 live vaccine has also been shown to be effective in lab studies. More encouraging news from this discovery is that this particular live vaccine could be effective against different variants of H5N1.
– The vaccine strategy using Virus Like Particles (VLPs) to induce an immune response can make the immune response more robust when confronted against a real virus. VLP strategy can have a wider affect across a wide variety of viruses which vaccines are being developed for.
All of these strategies are just a small number of ways by which vaccines are being developed to combat influenza. There are a couple of general strategies for vaccine development, using the virus itself or using the DNA of the virus to develop a vaccine. The work being done to combat influenza can have a influence on development of vaccines for other viruses of medical importance.
Reports via: http://www.physorg.com/biology-news/microbiology/